State Releases Fact Sheet on Preparing for Patients Using Concentrated 7-OH Products

September 3, 2026

The Minnesota Department of Health (MDH), in collaboration with the MMA and partner physicians, has released an informational brief on concentrated 7‑hydroxymitragynine (7‑OH) and other kratom products, which are increasingly available in commercial forms such as tablets, gummies, liquids, and “enhanced” or “spiked” kratom products.

The brief provides information for clinicians, including:

awareness of the DEA’s temporary scheduling of substances related to 7‑OH,

information on how concentrated 7‑OH products may produce stronger opioid‑like effects than typical kratom products, and

considerations for clinical settings that may encounter patients presenting with intoxication or withdrawal associated with these products.

The brief is intended to support situational awareness and preparedness across Minnesota healthcare settings. Please share across clinical teams.

Latest News

National Medical Specialty Societies Offer Vaccine Guidance

September 3, 2026

On September 2, the Vaccine Integrity Project (VIP) at the University of Minnesota’s Center for Infectious Disease Research and Policy, the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists, the American Academy of Family Physicians, and the Infectious Diseases Society of America issued guidelines recommending Americans continue to get immunized for influenza, COVID-19, and respiratory syncytial virus (RSV).

Sanford Health and North Memorial Health Finalize Partnership

September 3, 2026

On September 1, Sanford Health and North Memorial Health announced that they had finalized their partnership, and are now one non-profit integrated health system operating as Sanford Health.